Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI
Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.
The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.
Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.
-
Dr. Kelly Crotty Program Director, Center for Strategic Scientific Initiatives NCI
-
Pentagon Taps Gavin Kliger as CDO Amid AI Push
Gavin Kliger will help coordinate the Pentagon’s growing AI initiatives as leaders overhaul acquisition processes to deliver advanced capabilities faster.
3m read -
Army’s FUZE Program Speeds Path to Fielding Emerging Tech
Director Matthew Willis says FUZE is reshaping defense innovation by funding prototypes quickly and scaling successful tech in months instead of years.
4m read -
Staying Ahead of AI-Driven Cyber Threats
Robert Roser shares insights on emerging cybercrime trends, supply chain risks and how federal organizations can build stronger security through zero trust.
8m watch -
AI's Impact on Warfighting Starts With Logistics
CIO Adarryl Roberts discussed how a connected enterprise framework for AI is helping transform supply chain operations and improve readiness.
4m read
